Literature DB >> 15717949

Prevention of head and neck cancer.

Terry A Day1, Angela Chi, Brad Neville, James R Hebert.   

Abstract

In the vast majority of cases, head and neck cancer is a preventable disease. The relationship between tobacco and alcohol and these cancers is well established. Despite efforts aimed at reduction of risk factor exposure and early detection methods, head and neck cancer remains one of the more common cancers worldwide. Recent advances in molecular techniques have provided a framework for future targets for early diagnosis and treatment of these malignancies. This review provides a summary of recent developments in primary and secondary prevention of head and neck cancer and innovative strategies aimed at a reduction in incidence and mortality from this disease. The future prevention of head and neck cancer will likely require solutions to the widespread use of tobacco products and innovative diagnostic techniques leading to improvements in overall survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717949     DOI: 10.1007/s11912-005-0041-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  81 in total

1.  A causal role for human papillomavirus in head and neck cancer.

Authors:  M L Gillison; D R Lowy
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

2.  Cyclooxygenase inhibition as a target for prevention of tobacco-related cancers.

Authors:  Jay O Boyle
Journal:  Clin Cancer Res       Date:  2004-03-01       Impact factor: 12.531

Review 3.  Lichen planus and oral cancer: is there a connection between the two?

Authors:  E Eisenberg
Journal:  J Am Dent Assoc       Date:  1992-05       Impact factor: 3.634

4.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.

Authors:  M Relf; S LeJeune; P A Scott; S Fox; K Smith; R Leek; A Moghaddam; R Whitehouse; R Bicknell; A L Harris
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

5.  Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.

Authors:  Dosia Antonadou; Marizenia Pepelassi; Maria Synodinou; Maria Puglisi; Nicolas Throuvalas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-01       Impact factor: 7.038

6.  Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.

Authors:  J J Sciubba
Journal:  J Am Dent Assoc       Date:  1999-10       Impact factor: 3.634

7.  High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.

Authors:  H Kashiwazaki; H Tonoki; M Tada; I Chiba; M Shindoh; Y Totsuka; R Iggo; T Moriuchi
Journal:  Oncogene       Date:  1997-11-27       Impact factor: 9.867

8.  Influence of time delay and clinical upstaging in the prognosis of head and neck cancer.

Authors:  L P Kowalski; A L Carvalho
Journal:  Oral Oncol       Date:  2001-01       Impact factor: 5.337

9.  Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer.

Authors:  M-N Shiu; T H-H Chen
Journal:  Eur J Cancer Prev       Date:  2004-02       Impact factor: 2.497

10.  Oral cancer information in health education textbooks.

Authors:  Mary Anne S Baysac; Alice M Horowitz; Deuk-Sang Ma
Journal:  J Cancer Educ       Date:  2004       Impact factor: 2.037

View more
  4 in total

Review 1.  Basic consideration of research strategies for head and neck cancer.

Authors:  Jin Gao; Ben Panizza; Newell W Johnson; Scott Coman; Alan R Clough
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

2.  Association of tobacco habits, including bidi smoking, with overall and site-specific cancer incidence: results from the Mumbai cohort study.

Authors:  Mangesh S Pednekar; Prakash C Gupta; Balkrishna B Yeole; James R Hébert
Journal:  Cancer Causes Control       Date:  2011-03-24       Impact factor: 2.506

3.  Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.

Authors:  Kavita Malhotra Pattani; Zhe Zhang; Semra Demokan; Chad Glazer; Myriam Loyo; Steven Goodman; David Sidransky; Francisco Bermudez; Germain Jean-Charles; Thomas McCaffrey; Tapan Padhya; Joan Phelan; Silvia Spivakovsky; Helen Yoo Bowne; Judith D Goldberg; Linda Rolnitzky; Miriam Robbins; A Ross Kerr; David Sirois; Joseph A Califano
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-26

4.  Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

Authors:  Dong M Shin; Hongzheng Zhang; Nabil F Saba; Amy Y Chen; Sreenivas Nannapaneni; A R M Ruhul Amin; Susan Müller; Melinda Lewis; Gabriel Sica; Scott Kono; Johann C Brandes; William J Grist; Rachel Moreno-Williams; Jonathan J Beitler; Sufi M Thomas; Zhengjia Chen; Hyung Ju C Shin; Jennifer R Grandis; Fadlo R Khuri; Zhuo Georgia Chen
Journal:  Clin Cancer Res       Date:  2013-02-19       Impact factor: 12.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.